Arnd Heiligenhaus
About
In The Last Decade
Arnd Heiligenhaus
236 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Ophthalmology 3.6k
- Rheumatology 1.4k
- Hematology 1.4k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Public Health, Environmental and Occupational Health 1.0k
Countries citing papers authored by Arnd Heiligenhaus
This map shows the geographic impact of Arnd Heiligenhaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnd Heiligenhaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnd Heiligenhaus more than expected).
Fields of papers citing papers by Arnd Heiligenhaus
This network shows the impact of papers produced by Arnd Heiligenhaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnd Heiligenhaus. The network helps show where Arnd Heiligenhaus may publish in the future.
Co-authorship network of co-authors of Arnd Heiligenhaus
This figure shows the co-authorship network connecting the top 25 collaborators of Arnd Heiligenhaus. A scholar is included among the top collaborators of Arnd Heiligenhaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnd Heiligenhaus. Arnd Heiligenhaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 18 | |
| 3 | 6 | |
| 4 | 7 | |
| 5 | An amino acid motif in HLA-DRβ1 distinguishes patients with uveitis in juvenile idiopathic arthritis | 1 |
| 6 | 9 | |
| 7 | Adalimumab in Patients with Active Noninfectious Uveitis breakdown → | 418 |
| 8 | Adalimumab in Patients with Active, Noninfectious Uveitis Using High-Dose Corticosteroids | 0 |
| 9 | Behavioural conditioning of immune response with cyclosporine A in a model of experimental autoimmune uveitis (EAU) mitigates Th1 immune response but antagonizes Th17 responses | 1 |
| 10 | 7 | |
| 11 | „Herpeskeratitis“: Unterschiedliche Ausprägungsformen erfordern unterschiedliche Therapieansätze | 6 |
| 12 | Effect of Systemic or Intravitreal Anti Tumor Necrosis Factor-alpha Treatment in Experimental Autoimmune Uveoretinitis | 1 |
| 13 | 6 | |
| 14 | 29 | |
| 15 | Uveal and Capsular Biocompatibility of Two Acrylic Intraocular Lenses in Patients With Non-infectious Uveitis | 1 |
| 16 | Influence of Amniotic Membrane on Macrophage Functions in the Absence of Interferon-Gamma | 1 |
| 17 | 1 | |
| 18 | 18 | |
| 19 | 1 | |
| 20 | 44 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.